Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
allogeneic mesenchymal stem cells (1 trial)
alteplase (Activase) (1 trial)
apalutamide (erleada) (1 trial)
argatroban (1 trial)
ipilimumab (yervoy) (1 trial)
leuprolide (lupron) (1 trial)
nelfinavir (viracept) (1 trial)
vitespen (1 trial)
Cerebral Infarction (Phase 2)
Cervical Intraepithelial Neoplasia (Phase 2)
Ischemia (Phase 2)
Melanoma (Phase 2)
Prostatic Neoplasms (Phase 2)
Stroke (Phase 2)
Uterine Cervical Dysplasia (Phase 2)
Trials (5 total)
Trial APIs (8 total)